General Session 1: Genomics and Signalling Pathways

Chairs: Xin Wei Wang, PhD (USA) and Jessica Zucman-Rossi, MD, PhD (France)

  • O-001 High Frequency of Telomerase Reverse Transcriptase (Tert) Promoter Somatic Mutations in Hepatocellular Carcinoma and Pre-Neoplastic Lesions
    J. C. Nault, M. Mallet, C. Pilati , J. Calderaro, P. Bioulac-Sage, C. Laurent, A. Laurent, D. Cherqui, C. Balabaud, J. Zucman-Rossi

  • O-002 Genome Wide Methylation Analysis and Epigenetic Unmasking Reveals Silenced Tumor Suppressor Genes in Hepatocellular Carcinoma
    K. Revill, T. Wang, A. Lachenmayer, K. Kojima, A. Harrington, J. Li, Y. Hoshida, J. M. Llovet, S. Powers

  • O-003 Decoding the Sequential Evolution of Human Hepatocarcinogenesis by Next-Generation Rna Sequencing: Mechanistic and Clinical Implications
    J. U. Marquardt, D. Seo, J. B. Andersen, M. C. Gillen, M. S. Kim, E. A. Conner, P. R. Galle, V.M. Factor, Y. N. Park, S. S. Thorgeirsson

  • O-005 Exome Sequencing of Hepatocellular Adenomas Identify Alterations Involved in Malignant Transformation and New Frk Oncogenic Mutations
    C. Pilati, E. Letouzé, J.-C. Nault, S. Imbeaud, A. Boulai, J. Calderaro, P. Bioulac-Sage, J. Zucman-Rossi

  • O-006 Specifically Altered Micrornas Novel in Regulatory T Cells Activated by Mouse Hepatocellular Carcinoma
    C. Liang, L. Chen, H. Hu, H. Ma, F. Wang, X. Wang, J. Ma, G. Zhou